OSRX Pharmaceuticals

Post-Op Care

Glaucoma Care

Low-Dose Atropine

Ophthalmic Injections

Glaucoma Care

Prescribing OMNI:  New prescribers must complete and submit an OSRX new prescriber registration form. Once received, an OSRX staff member will promptly contact you to discuss pricing and ordering specifics.

Glaucoma medications carry serious risks, including burning and stinging upon instillation, allergic conjunctivitis and bitter taste in mouth. Cick here to view a full list of potential adverse events and contraindications.

Ready to save your patients up to 60% on their monthly drops? Learn more about discounts in our AutoRefill Program, starting at $20 per bottle.

Questions? Check out our FAQ. 

Timolol 0.5%
Bimatoprost 0.01%
Sterile Ophthalmic Solution 

Potential Adverse Events & Contraindications

5 mL

Timolol 0.5%
Brimonidine Tartrate 0.1%
Dorzolamide 2%
Sterile Ophthalmic Solution 

Potential Adverse Events & Contraindications

5 mL

Timolol 0.5%
Brimonidine Tartrate 0.1%
Dorzolamide 2%
Bimatoprost 0.01%
Sterile Ophthalmic Solution

Potential Adverse Events & Contraindications

5 mL

Brimonidine Tartrate 0.1%
Dorzolamide 2%
Sterile Ophthalmic Solution 

Potential Adverse Events & Contraindications 

2 & 5 mL

Bimatoprost 0.01%
Dorzolamide 2% Timolol 0.5%
Sterile Ophthalmic Solution 

Potential Adverse Events & Contraindications 

5 mL

Bimatoprost 0.01%
Brimonidine Tartrate 0.1%
Dorzolamide 2%
Sterile Ophthalmic Solution 

Potential Adverse Events & Contraindications 

5 mL

OSRX medications carry serious risks. Please click here to view potential adverse events and contraindications.

*For professional use only. OSRX specializes in customizing compounded medications to meet unique patient needs. Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality.

OSRX medications carry serious risks. Please click here to view potential adverse events and contraindications.

*For professional use only. OSRX specializes in customizing compounded medications to meet unique patient needs. Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality.